Category: Markets
Published: 2026-07-16T11:42:09.000Z
Abbott Laboratories has increased its 2026 profit guidance following a better-than-expected second quarter. The company now anticipates adjusted earnings per share to be between $5.45 and $5.60, representing a 5-cent improvement at the midpoint. This positive outlook is attributed to strong performance across most of its business lines, with both profit and sales exceeding Wall Street estimates.
News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.